In our analysis, IL21R was specifically upregulated, and this high expression predicted high RFS and OS (p < 0.05) in Her2-subtype breast cancer, which was consistent with the prognostic analysis results in all breast cancer. This evidence concerns the gene ERBB2 and breast cancer.